Wan 2009.

Methods	Randomisation mentioned, but not described in detail
Participants	Country: China Primary nephrotic syndrome patients (urinary protein > 3.5g /24 h; plasma albumin < 30 g/dL; oedema and hypercholesterolaemia) Number: treatment group (50); control group (46) Age range: 130 75 years Sex (M/F): NS Exclusions: secondary nephrotic syndrome
Interventions	Treatment group Huangqi and Danggui Dose: twice a day for 8 weeks Drugs the control group received Control group Prednisone Dose: 1 mg/kg/d
Outcomes	Plasma albumin 24 hours urine protein Blood cholesterol Blood triglyceride Effective rate
Notes	Baseline declining kidney function: NS Remission: NS Pathology: described in detail Relapse: NS Time to relapse: NS Mean follow‐up: NS Dosage: described in detail Prepare method: NS Source of funding: none